| Resistant starch: a promising dietary agent for the prevention/treatment of inflammatory bowel disease and bowel cancer. | |
| | |
MedLine Citation:
|
PMID: 23385525 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
PURPOSE OF REVIEW: Resistant starch represents a diverse range of indigestible starch-based dietary carbohydrates. Resistant starch has been investigated in the past for its effects on bowel health (pH, epithelial thickness, and apoptosis of colorectal cancer cells); reduction in postprandial glycemia; increased insulin sensitivity; and effects on the gut microbiome. This review highlights advances as resistant starch gains clinical relevance as a potential treatment/preventive tool for diseases such as colorectal cancer (CRC) and diabetes. RECENT FINDINGS: Recent articles have evaluated the comparative physiological effects of different types of resistant starch and investigated the effects of resistant starch on blood lipids, body weight, and defining resistant starch-induced changes to the micriobiome that may be important in health and disease. The most novel and relevant recent data describe a role for resistant starch in ameliorating inflammation; the use of resistant starch for optimal bowel health and prevention of CRC; and, further, that the systemic effects of resistant starch may be important for the treatment of other forms of cancer, such as breast cancer. SUMMARY: This review describes advances in resistant starch research highlighting the gastrointestinal effects that are now being linked to systemic, whole body effects with clinical relevance. These effects have important implications for overall health and the prevention or amelioration of various chronic diseases. |
| | |
Authors:
|
Janine A Higgins; Ian L Brown |
Related Documents
:
|
17393945 - Analysis of prostate cancer incidence using geographic information system and multileve... 16869975 - Early cancer detection among rural and urban californians. 10470455 - History and international developments in cancer staging. 1962775 - Diagnosing and staging of non-small cell lung cancer. 19175655 - Growth pattern in the muscular layer reflects the biological behaviour of colorectal ca... 21213205 - Management of pleural effusion in the cancer patient. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Current opinion in gastroenterology Volume: 29 ISSN: 1531-7056 ISO Abbreviation: Curr. Opin. Gastroenterol. Publication Date: 2013 Mar |
Date Detail:
|
Created Date: 2013-02-06 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8506887 Medline TA: Curr Opin Gastroenterol Country: United States |
Other Details:
|
Languages: eng Pagination: 190-4 Citation Subset: IM |
Affiliation:
|
aCenter for Human Nutrition bDepartment of Pediatrics, Anschutz Medical Campus, University of Colorado Denver cChildren's Hospital Colorado, Aurora, Colorado, USA dSchool of Medicine, Faculty of Health Sciences, Flinders University, South Australia, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Potent Inhibition of HIV-1 Reverse Transcriptase and Replication by Nonpseudoknot, "UCAA-motif" RNA ...
Next Document: Nutrition and diet in inflammatory bowel disease.